Surgalign Holdings Announces the Commercial Launch of ViBone® Moldable and the First Clinical Implantation
January 12, 2021 at 09:00 am EST
Surgalign Holdings, Inc. announced the commercial launch and the completion of the first surgery of ViBone Moldable in the US. The first implantation was completed by Dr. Adam Crowl, at OrthoVirgina in Midlothian, VA. ViBone Moldable is the newest orthobiologics solution of Surgalign’s bone graft portfolio to support spinal fusion, which currently include ViBone and other advanced bone graft solutions.